Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers.
Helena P I LinaresFrederik ChristiansenSigne Holm NielsenPeder FrederiksenAnne-C Bay-JensenMorten Asser KarsdalSengul SevenInge Juul SørensenAnne Gitte LoftOle Rintek MadsenMikkel OstergaardSusanne J PedersenPublished in: RMD open (2024)
These endotypes differ in their tissue remodelling profile and may in the future have utility for patient stratification and treatment tailoring.